Nationwide trends of hospitalizations for cystic fibrosis in the United States from 2003 to 2013
- PMID: 28944141
- PMCID: PMC5608929
- DOI: 10.5582/irdr.2017.01043
Nationwide trends of hospitalizations for cystic fibrosis in the United States from 2003 to 2013
Abstract
Cystic fibrosis (CF) is a multisystem autosomal recessive genetic disorder with significant advances in early diagnosis and treatment in the last decade. It is important to provide updated information regarding these changing demographics as they also reflect a considerable improvement in survival. We analyzed the National Inpatient Sample Database (NIS) in the United States for all patients in which CF was the primary discharge diagnosis (ICD-9: 277.0-277.09) from 2003 to 2013 to evaluate the rate of hospitalizations and determine the cost and mortality associated with CF along with other epidemiological findings. The statistical significance of the difference in the number of hospital discharges, lengths of stays and associated hospital costs over the study period was calculated. In 2003, there were 8,328 hospital discharges with the principal discharge diagnosis of CF in the United States, which increased to 12,590 discharges in 2013 (p < 0.001). The mean hospital charges increased by 57.64% from US$ 60,051 in 2003 to US$ 94,664 in 2013. The aggregate cost of hospital visits increased by 138.31% from US$ 500,105,727 to US$ 1,191,819,760. In the same time, the mortality decreased by 49.3 %. The number of inpatient discharges related to CF has increased from 2003 to 2013. This is due to increased life expectancy of CF patients, resulting in increased disease prevalence. There has been a significant increase in the mean and aggregate cost associated with CF admissions. Over the last decade, many advances have been made in the diagnosis and treatment of CF, consequentially leading to a significant transformation in the epidemiology and demographics of this chronic disease. Rising hospital costs associated with the care of CF patients necessitates future studies analyzing the diagnostic modalities, algorithms and treatment practices of physician's treating CF patients.
Keywords: Cystic Fibrosis; epidemiology; healthcare burden; hospitalizations; length of stay; mortality.
Figures
Similar articles
-
Nationwide trends in inpatient admissions of pulmonary hypertension in the United States from 2000 to 2013.Adv Respir Med. 2017;85(2):77-86. doi: 10.5603/ARM.2017.0014. Adv Respir Med. 2017. PMID: 28440533
-
Nationwide trends of hospital admissions for acute cholecystitis in the United States.Gastroenterol Rep (Oxf). 2017 Feb;5(1):36-42. doi: 10.1093/gastro/gow015. Epub 2016 May 11. Gastroenterol Rep (Oxf). 2017. PMID: 27174434 Free PMC article.
-
Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective.J Hematol Oncol. 2018 Dec 13;11(1):138. doi: 10.1186/s13045-018-0682-5. J Hematol Oncol. 2018. PMID: 30545376 Free PMC article.
-
Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.Pharmacoeconomics. 2003;21(14):1001-24. doi: 10.2165/00019053-200321140-00002. Pharmacoeconomics. 2003. PMID: 13129414 Review.
-
Trends and Projections in U.S. Hospital Costs by Patient Age, 2003–2013.2014 Jul. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb–. Statistical Brief #176. 2014 Jul. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb–. Statistical Brief #176. PMID: 25254288 Free Books & Documents. Review.
Cited by
-
Development of a Cystic Fibrosis Primary Palliative Care Intervention: Qualitative Analysis of Patient and Family Caregiver Preferences.J Patient Exp. 2023 Mar 15;10:23743735231161486. doi: 10.1177/23743735231161486. eCollection 2023. J Patient Exp. 2023. PMID: 36936380 Free PMC article.
-
Assessing Practices, Beliefs, and Attitudes about Palliative Care among People with Cystic Fibrosis, Their Caregivers, and Clinicians: Results of a Content Analysis.J Palliat Med. 2021 Nov;24(11):1650-1656. doi: 10.1089/jpm.2020.0725. Epub 2021 Apr 20. J Palliat Med. 2021. PMID: 33885355 Free PMC article.
-
Developing a Decision Aid to Facilitate Informed Decision Making About Invasive Mechanical Ventilation and Lung Transplantation Among Adults With Cystic Fibrosis: Usability Testing.JMIR Hum Factors. 2021 Apr 14;8(2):e21270. doi: 10.2196/21270. JMIR Hum Factors. 2021. PMID: 33851921 Free PMC article.
-
The effectiveness and value of novel treatments for cystic fibrosis.J Manag Care Spec Pharm. 2021 Feb;27(2):276-280. doi: 10.18553/jmcp.2021.27.2.276. J Manag Care Spec Pharm. 2021. PMID: 33506736 Free PMC article.
-
Practitioner Due Diligence: Real-World Lumacaftor/Ivacaftor Use.J Pediatr Pharmacol Ther. 2020;25(5):431-436. doi: 10.5863/1551-6776-25.5.431. J Pediatr Pharmacol Ther. 2020. PMID: 32641913 Free PMC article.
References
-
- Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: A clinical and pathologic study. Am J Dis Child. 1938; 56:344-399.
-
- Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahei R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science. 1989; 245:1066-1073. - PubMed
-
- Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996; 335:179-188. - PubMed
-
- Cystic Fibrosis Foundation Patient Registry 2015. https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Regist... (accessd January 24, 2017).
-
- Marshall BC, Campbell PW., 3rd Improving the care of infants identified through Cystic Fibrosis newborn screening. J Pediatr. 2009; 155:S71-S72. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources